Novel Androgen Receptor-Targeting Therapies May Overcome Castration Resistance in Aggressive Prostate Cancer

Androgen deprivation therapy, which prevents androgen receptor signaling, initially is effective against advanced prostate cancer but progression eventually resumes, relying on androgen receptor’s transcriptional activity. Cleveland Clinic researchers are exploring new approaches that block this transactivation function, which may prevent or overcome resistance.